Business Standard

Bharat Biotech's coronavirus vaccine may be launched in February

Moderna and AstraZeneca are close behind the largest US drugmaker and are likely to have early data on their vaccine candidates before the end of the year.

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

Moderna and AstraZeneca are close behind the largest US drugmaker and are likely to have early data on their vaccine candidates before the end of the year.

Krishna N Das | Reuters New Delhi
India is racing ahead with work on its coronavirus vaccine while Britain’s AstraZeneca says its deliveries are running ‘a little bit late’ as countries around the world seek to conquer the pandemic and rescue their economies.
 
A vaccine is seen as the world’s best bet for taming a virus that has infected more than 48 million people, led to more than 1.2 million deaths, roiled economies and disrupted billions of lives since it was first identified in China in December.
 
Australia is beefing up its prospective arsenal against the pandemic to 135 million doses of various vaccine candidates.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in